MedPath

A randomised, double blind, placebo controlled study to assess the effect of testosterone treatment on arterial stiffness in patients with type 2 diabetes, peripheral vascular disease and hypogonadism. - Testosterone Replacement in Diabetes and Vascular Disease

Phase 1
Conditions
Male Hypogonadism
Registration Number
EUCTR2005-003652-35-GB
Lead Sponsor
Barnsley Hospital NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
30
Inclusion Criteria

Male patients greater than 18 years of age.
Type 2 diabetes mellitus
Hypogonadism- serum testosterone less than 11 nmol/L on two samples
Peripheral Vascular Disease- ankle-brachial-pressure index <0.92 at baseline and symptoms.
Ability and agreement to comply with trial requirements after explanation in english language.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Current or previous breat or prostate malignancy.
Other active malignancy.
Raised prostate specific antigen level or abnormal rectal examination until cancer ruled out by specialist.
Treatment with testosterone in last three months.
Treatment with hormonallt active treatment apart from for diabetes in the last three months.
Involvement in another clinical trial in the last three months.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath